Pharmacologic and clinical assessment of kratom.

@article{White2018PharmacologicAC,
  title={Pharmacologic and clinical assessment of kratom.},
  author={C Michael White},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  year={2018},
  volume={75 5},
  pages={
          261-267
        }
}
PURPOSE This article reviews the pharmacology, clinical utility, adverse effects, and abuse potential of kratom. SUMMARY The leaves of Mitragyna speciosa contain the biologically active alkaloids of kratom. Kratom exerts opioid and α-2 receptor agonistic effects as well as antiinflammatory and parasympathetic-impeding effects. There are no published human pharmacologic, pharmacokinetic, or drug interaction studies on kratom or mitragynine, making it virtually impossible to fully understand… CONTINUE READING
55
Twitter Mentions

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Dozens of congressmen ask DEA not to ban Kratom next week (September 23, 2016)

S. Nelson
  • www.usnews. com/news/articles/2016-09-23/45congressmen-ask-dea-not-to-bankratom-next-week (accessed
  • 2016
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

States ban kratom supplement over abuse worries (May 20, 2016)

M. Brown
  • www.usnews.com/news/ us/articles/2016-05-20/states-bankratom-supplement-over-abuseworries (accessed
  • 2016
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Kratom exposures reported to Texas poison centers.

  • Journal of addictive diseases
  • 2013
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL